Maspin inhibition of tpa activity

摘要

A method for controlling the in vivo activity of tissue plasminogen activator (tPA) is described. The method includes steps of (a) administering a therapeutically effective amount of tPA to a mammalian subject and (b) administering a therapeutically effective amount of maspin to the mammal. The maspin is administered when excessive tPA activity is detected in vivo.